Category Archives: Cardiovascular

SPOTLIGHT: Statin lowers cardiovascular disease risk in people living with HIV, large study finds

HIV increases a person’s risk of developing cardiovascular disease (CVD), but there are unanswered questions about how to best manage this elevated risk. One such question is whether using a class of cholesterol-lowering medications called statins could reduce the risk of major adverse cardiovascular events (MACE) in people living with HIV who have a low […]

Exercise plays a key part in HCM management

Matthew Martinez, MD, director of the Atlantic Health System Sports Cardiology at Morristown Medical Center and a nationally recognized HCM expert, spoke with Cardiovascular Business at the American Society of Echocardiography (ASE) 2023 meeting. He explained how HCM care management is changing and how it is not as rare of a disease as previously believed.  […]

Study reveals key mechanism linking obstructive sleep apnea and cardiovascular disease

Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing. Obstructive sleep apnea has long been associated with increased risk of cardiovascular issues, including heart attack, stroke, and death, but the findings from this study, partially supported by the National […]

Patients With HIV Have Lower Risk of Cardiovascular Events When Treated with Pitavastatin

Patients with HIV administered antiretroviral therapy (ART) and who were treated with pitavastatin had a lower risk of a major adverse cardiovascular event (MACE) than those who received a placebo, according to the results of a study published in The New England Journal of Medicine. Image credit: artegorov3@gmail – stock.adobe.com Criteria for participation in the […]

Increased Cardiovascular Risks from Obstructive Sleep Apnea Caused by Reduced Blood Oxygen Levels

Credit: grandriver/Getty Images The association between obstructive sleep apnea and the risk of developing cardiovascular condition is well established. Now, new research published in the American Journal of Respiratory and Critical Care Medicine, by Harvard Medical School and Brigham and Women’s Hospital investigators has shown that increased cardiovascular risks from obstructive sleep apnea are caused […]

NIH-funded study explains link to increased cardiovascular risks for

News Release Wednesday, July 26, 2023 Reduction in blood oxygen levels, largely attributed to blocked airways, emerges as a leading factor. Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing. Obstructive sleep apnea has long been associated with increased […]

$2.1 million awarded to research link between migraine, strokes and cardiovascular disease

The American Heart Association is funding seven new scientific research studies to learn more about the way migraine may impact the risk of stroke and heart disease DALLAS, July 26, 2023 — Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead […]

Pregnancy Loss Linked to Increased Risk of Heart Attack in Women, But Not Male Partners

Anders Pretzmann Mikkelsen, MD, PhDCredit: LinkedIn An analysis of data from more than 1.1 million women and their male partners is providing new insight into differences in risk of myocardial infarction and all-cause mortality following pregnancy loss. A register-based cohort study including all people born in Denmark between 1957 and 1997, results indicate experiencing pregnancy […]

Viva Biotech and Pfizer Collab on Cardiovascular Treatment Initiative

26 July 2023 Science Viva Biotech’s investment enterprise, Riparian Pharmaceuticals, works to develop cutting-edge treatments for cardiovascular conditions. Riparian has recently revealed an exclusive deal with Pfizer on a research and licence contract. “Riparian Pharmaceuticals works to develop cutting-edge treatments for cardiovascular conditions“ Pfizer will provide Riparian with sole access to one of their preclinical […]